US Bancorp
COGT icon

US Bancorp’s Cogent Biosciences COGT Stock Holding History

US Bancorp’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$470K Buy
12,210
+12,052
+7,628% +$445K ﹤0.01% 1542
2025
Q4 		$5.61K Buy
+158
New +$4.44K ﹤0.01% 3492
2025
Q3 		– Sell
-31
Closed -$223 – 4065
2025
Q2 		$223 Sell
31
-195
-86% -$1.08K ﹤0.01% 4070
2025
Q1 		$1.35K Buy
+226
New +$1.77K ﹤0.01% 3940
2024
Q3 		– Sell
-137
Closed -$1.16K – 4099
2024
Q2 		$1.16K Buy
+137
New +$1.04K ﹤0.01% 3793
2023
Q4 		– Sell
-245
Closed -$2.39K – 4001
2023
Q3 		$2.39K Sell
245
-188
-43% -$2.23K ﹤0.01% 3617
2023
Q2 		$5.13K Sell
433
-2,811
-87% -$32.3K ﹤0.01% 3469
2023
Q1 		$35K Sell
3,244
-498
-13% -$6.37K ﹤0.01% 2695
2022
Q4 		$43.3K Buy
3,742
+1,518
+68% +$18.8K ﹤0.01% 2613
2022
Q3 		$33K Buy
2,224
+923
+71% +$12.7K ﹤0.01% 2768
2022
Q2 		$12K Buy
+1,301
New +$8.88K ﹤0.01% 3293
2021
Q3 		– Sell
-61
Closed – – 4091
2021
Q2 		$0 Buy
+61
New +$515 ﹤0.01% 4009

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

US Bancorp's COGT Position: Q1 2026 in Review

US Bancorp increased its Cogent Biosciences (COGT) stake by 7,628% in Q1 2026, buying an estimated $445K and bringing the position to 12,210 shares worth $470K. The position accounts for ﹤0.01% of the portfolio, ranked #1542.

US Bancorp first reported a position in COGT in Q2 2021 and has held it in 12 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • US Bancorp held 12,210 shares of Cogent Biosciences worth $470K as of Q1 2026.
  • US Bancorp bought 12,052 Cogent Biosciences shares in Q1 2026, an estimated $445K.
  • Cogent Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q1 2026, its #1542 holding.
  • US Bancorp first reported a position in Cogent Biosciences in Q2 2021 and has held it in 12 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on US Bancorp's 13F filing for Q1 2026, filed 15 May 2026.